Impacts of a mass vaccination campaign against pandemic H1N1 2009 influenza in Taiwan: A time-series regression analysis

International Journal of Infectious Diseases

Volumn 23, Issue , 2014, Pages 82-89

  Wu, Un In ^a   Wang, Jann Tay ^a   Chang, Shan Chwen ^a   Chuang, Yu Chung ^a   Lin, Wei Ru ^b   Lu, Min Chi ^c   Lu, Po Liang ^b   Hu, Fu Chang ^d   Chuang, Jen Hsiang ^e   Chen, Yee Chun ^a   Hsieh, Szu Min ^f   Chien, Shu Fen ^f   Chang, Hsin Hsin ^f   Chang, Yin Yin ^f   Lin, Hui Chi ^f   Hong, Mei Chuan ^f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CENTER FOR DISEASE CONTROL   (Taiwan)

^f Taiwan Centers for Disease Control ^*

Author keywords

Effectiveness; Influenza; Mass vaccination; Pandemic; Prioritization; Time series regression analysis

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOGENICITY; INFANT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MULTICENTER STUDY; OUTPATIENT; PHARMACEUTICAL CARE; POTENTIAL DIFFERENCE; SURGICAL MASK; TAIWAN; TERTIARY CARE CENTER; TIME SERIES ANALYSIS; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMIC; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LINEAR MODELS; MASS VACCINATION; MIDDLE AGED; PANDEMICS; TAIWAN; YOUNG ADULT;

EID: 84899865674     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.02.016     Document Type: Article

References (52)

1. World Health Organization. Influenza update - 119. Geneva: WHO; 2010. Available at: (accessed October 20, 2010). http://www.who.int/csr/disease/influenza/2010_10_20_GIP_surveillance/en/index.html.
2. World Health Organization. Safety of pandemic vaccines. Geneva: WHO; 2009. Available at: (accessed September 18, 2009). http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/index.html.
3. Wang C.S., Wang S.T., Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002, 20:2494-2499.
4. Wang S.T., Lee L.T., Chen L.S., Chen T.H. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine 2005, 23:1973-1980.
5. Hsieh Y.C., Chen H.Y., Yen J.J., Liu D.P., Chang L.Y., Lu C.Y., et al. Influenza in Taiwan: seasonality and vaccine strain match. J Microbiol Immunol Infect 2005, 38:238-243.
6. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009. MMWR Morb Mortal Wkly Rep 2009, 58(RR-8):1-52. US Centers for Disease Control and Prevention.
7. Use of Influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009. MMWR Recomm Rep 2009, 58(RR-10):1-8. US Centers for Disease Control and Prevention.
8. World Health Organization. Global pandemic influenza action plan to increase vaccine supply. Geneva: WHO; 2006. Available at: (accessed January 5, 2011). http://sowf.moi.gov.tw/stat/year/elist.htm.
9. Glasser J, Taneri D, Feng Z, Chuang JH, Tull P, Thompson W, et al. Evaluation of targeted influenza vaccination strategies via population modeling. PLoS One 2010;5. pii: e12777. doi: 10.1371/journal.pone.0012777.
10. Taiwan Center for Disease Control. 2009 Focus-H1N1 pandemic preparedness and response. Taiwan: CDC; 2010. Available at: (accessed March 1, 2011). http://flu.cdc.gov.tw/public/Data/010221520471.pdf.
11. Chuang J.H., Huang A.S., Huang W.T., Liu M.T., Chou J.H., Chang F.Y., et al. Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan. PLoS One 2012, 7:e36120.
12. Huang W.T., Chen W.W., Yang H.W., Chen W.C., Chao Y.N., Huang Y.W., et al. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan. Vaccine 2010, 28:7161-7166.
13. Kung H.C., Huang K.C., Kao T.M., Lee Y.C., Chang F.Y., Wang N.C., et al. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine 2010, 28:7337-7343.
14. Lu C.Y., Shao P.L., Chang L.Y., Huang Y.C., Chiu C.H., Hsieh Y.C., et al. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine 2010, 28:5864-5870.
15. Shumway R.H., Stoffer D.S. Time series analysis and its applications: with R examples 2006, Springer, New York, p. 176-81. 2nd ed.
16. Cryer J.D., Chan K.S. Time series analysis with applications in R 2008, Springer, New York, p. 34-5. 2nd ed.
17. Tsai M.T., Chern T.C., Chuang J.H., Hsueh C.W., Kuo H.S., Liau C.J., et al. Efficient simulation of the spatial transmission dynamics of influenza. PLoS One 2010, 5:e13292.
18. Taiwan Center for Disease Control. Taiwan Influenza Express 2011, week 20. Taiwan: CDC; 2011. Available at: (accessed May 8, 2011). http://flu.cdc.gov.tw/public/Data/15259381471.pdf.
19. Medlock J., Galvani A.P. Optimizing influenza vaccine distribution. Science 2009, 325:1705-1708.
20. Chowell G., Viboud C., Wang X., Bertozzi S.M., Miller M.A. Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One 2009, 4:e8164.
21. Tuite A.R., Fisman D.N., Kwong J.C., Greer A.L. Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One 2010, 5:e10520.
22. Fisman D. Modelling an influenza pandemic: a guide for the perplexed. CMAJ 2009, 181:171-173.
23. Kwong J.C., Ge H., Rosella L.C., Guan J., Maaten S., Moran K., et al. School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: an ecological study. Vaccine 2010, 28:2722-2729.
24. Boelle P.Y., Ansart S., Cori A., Valleron A.J. Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respi Viruses 2011, 5:306-316.
25. Chen C.J., Lee P.I., Chang S.C., Huang Y.C., Chiu C.H., Hsieh Y.C., et al. Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One 2011, 6:e24440.
26. Chan M.C., Chan R.W., Yu W.C., Ho C.C., Yuen K.M., Fong J.H., et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010, 176:1828-1840.
27. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
28. Dorigatti I., Cauchemez S., Ferguson N.M. Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England. Proc Natl Acad Sci U S A 2013, 110:13422-13427.
29. Lee B.Y., Brown S.T., Cooley P., Grefenstette J.J., Zimmerman R.K., Zimmer S.M., et al. Vaccination deep into a pandemic wave-potential mechanisms for a "third wave" and the impact of vaccination. Am J Prev Med 2010, 39:e21-e29.
30. Yu H., Cauchemez S., Donnelly C.A., Zhou L., Feng L., Xiang N., et al. Transmission dynamics, border entry screening, and school holidays during the 2009 influenza A (H1N1) pandemic, China. Emerg Infect Dis 2012, 18:758-766.
31. Orsted I., Molvadgaard M., Nielsen H.L., Nielsen H. The first, second and third wave of pandemic influenza A (H1N1)pdm09 in North Denmark Region 2009-2011: a population-based study of hospitalizations. Influenza Other Respi Viruses 2013, 7:776-782. 10.1111/irv.12093.
32. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
33. Taylor C., Marathe A., Beckman R. Same influenza vaccination strategies but different outcomes across US cities?. Int J Infect Dis 2010, 14:e792-e795.
34. Charu V., Viboud C., Simonsen L., Sturm-Ramirez K., Shinjoh M., Chowell G., et al. Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS One 2011, 6:e26282.
35. Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection-Connecticut, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1029-1032.
36. Chien Y.S., Su C.P., Tsai H.T., Huang A.S., Lien C.E., Hung M.N., et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010, 60:168-174.
37. Yen M.Y., Lee W.S., Hu P.H., Kuo B.I., Woung L.C., Chiu A.W., et al. Implementation of community influenza centers and vaccination campaign in protecting healthcare workers and control of pandemic (H1N1) 2009 in Taipei City, Taiwan. J Infect 2013, 67:242-244.
38. van der Goot J.A., Engel B., van de Water S.G., Buist W., de Jong M.C., Koch G., et al. Validation of diagnostic tests for detection of avian influenza in vaccinated chickens using Bayesian analysis. Vaccine 2010, 28:1771-1777.
39. Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P.Y., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012, 12:687-695.
40. Greenwood P.E., Gordillo L.F. Stochastic epidemic modeling. Mathematical and statistical estimation approaches in epidemiology 2009, 31-52. Springer, Dordrecht. G. Chowell, J.M. Hyman, L.M.A. Bettencourt, C. Castillo-Chavez (Eds.).
41. Lekone P.E., Finkenstadt B.F. Statistical inference in a stochastic epidemic SEIR model with control intervention: Ebola as a case study. Biometrics 2006, 62:1170-1177.
42. Medlock J., Meyers L.A., Galvani A. Optimizing allocation for a delayed influenza vaccination campaign. PLoS Curr 2009, 1:RRN1134.
43. Chowell G., Viboud C., Wang X., Bertozzi S., Miller M. Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS Curr 2009, 1:RRN1004.
44. Nishiura H., Castillo-Chavez C., Safan M., Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 2009, 14. pii: 19227.
45. Griffin M.R., Monto A.S., Belongia E.A., Treanor J.J., Chen Q., Chen J., et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011, 6:e23085.
46. Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., SebastianPillai P., et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011, 16. pii: 19763.
47. Valenciano M., Kissling E., Cohen J.M., Oroszi B., Barret A.S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8:e1000388.
48. Savulescu C., Jimenez-Jorge S., de Mateo S., Pozo F., Casas I., Brena P.P., et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health 2011, 11:899. 10.1186/1471-2458-11-899.
49. Chen W.C., Huang A.S., Chuang J.H., Chiu C.C., Kuo H.S. Social and economic impact of school closure resulting from pandemic influenza A/H1N1. J Infect 2011, 62:200-203.
50. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:826-829.
51. Likitnukul S., Boonsiri K., Tangsuksant Y. Evaluation of sensitivity and specificity of rapid influenza diagnostic tests for novel swine-origin influenza A (H1N1) virus. Pediatr Infect Dis J 2009, 28:1038-1039.
52. Lan Y.C., Su M.C., Chen C.H., Huang S.H., Chen W.L., Tien N., et al. Epidemiology of pandemic influenza A/H1N1 virus during 2009-2010 in Taiwan. Virus Res 2013, 177:46-54.